1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Aducanumab binding to Aβ1-42 fibrils alters dynamics of the N-terminal tail while preserving the fibril core
- Contribution to journal › Article
- 2023
-
Mark
Investigating Partially Discordant Results in Phase 3 Studies of Aducanumab
Mallinckrodt, C. ; Tian, Y. ; Aisen, P. S. ; Barkhof, F. ; Cohen, S. ; Dent, G. ; Hansson, O. LU
; Harrison, K.
; Iwatsubo, T.
and Mummery, C. J.
, et al.
(2023)
In Journal of Prevention of Alzheimer's Disease
10.
p.171-177
- Contribution to journal › Article
- 2022
-
Mark
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer’s Disease
Budd Haeberlein, Samantha ; Aisen, P. S. ; Barkhof, F. ; Chalkias, S. ; Chen, T. ; Cohen, S. ; Dent, G. ; Hansson, O. LU
; Harrison, K.
and von Hehn, C.
, et al.
(2022)
In Journal of Prevention of Alzheimer's Disease
9(2).
p.197-210
- Contribution to journal › Article